Clinical Trial

Quadratus Lumborum Versus Placebo in Open Ventral Hernia Repair

Study acronym: VHR
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 1, 2025 (before its estimated January 28, 2026 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this study is to determine whether using a QL block is better than placebo (a look-alike substance that contains no drug) in lowering the amount of opioids you need for pain relief in the first 24 hours and if it improves your recovery following a ventral hernia repair. Participants will be asked to complete a questionnaire before surgery and again at their 30-day follow up. You will also be asked to complete a pain diary 24 hours after surgery and attend a follow-up visit approximately 30 days after surgery. The following information will be collected from you or your medical record: 1. Pain medications given to you during surgery. 2. Pain medications prescribed to you after surgery, including medication name, dose, units, and frequency. 3. Pain levels during the first 24 hours after surgery. 4. Your total hospital length of stay after surgery. 5. Any complications that you may have experienced after surgery. 6. Demographic information, medical history as well as details about your hernia repair surgery.
Trial Details
NCT Number NCT06953635
Lead Sponsor University of Tennessee Graduate School of Medicine
Conditions Hernia, Ventral, Pain Management
Enrollment 70 participants
Start Date 2025-06-01
Primary Completion 2026-01-28 (estimated)
Study Completion 2026-02-28 (estimated)
Updated on ClinicalTrials.gov 2025-05-01